Watchtower/Law library/Money Laundering, Terrorist.../35 Enhanced customer due diligence:...
As last captured

Money Laundering, Terrorist Financing and Transfer of Funds... · CHAPTER 2 Enhanced customer due diligence

35 Enhanced customer due diligence: politically exposed persons

reg. 35 · in force: yes

Captured statutory text (L5)

35 Enhanced customer due diligence: politically exposed persons

(1)A relevant person must have in place appropriate risk-management systems and procedures to determine whether a customer or the beneficial owner of a customer is—
(a)a politically exposed person (a “PEP”); or
(b)a family member or a known close associate of a PEP,
and to manage the enhanced risks arising from the relevant person's business relationship or transactions with such a customer.
(2)In determining what risk-management systems and procedures are appropriate under paragraph (1), the relevant person must take account of—
(a)the risk assessment it carried out under regulation 18(1);
(b)the level of risk of money laundering and terrorist financing inherent in its business;
(c)the extent to which that risk would be increased by its business relationship or transactions with a PEP, or a family member or known close associate of a PEP, and
(d)any relevant information made available to the relevant person under regulations 17(9) and 47.
(3)If a relevant person has determined that a customer or a potential customer is a PEP, or a family member or known close associate of a PEP, the relevant person must assess—
(a)the level of risk associated with that customer, and
(b)the extent of the enhanced customer due diligence measures to be applied in relation to that customer.
(3A)For the purpose of the relevant person’s assessment under paragraph (3), where a customer or potential customer is a domestic PEP, or a family member or a known close associate of a domestic PEP—
(a)the starting point for the assessment is that the customer or potential customer presents a lower level of risk than a non-domestic PEP, and
(b)if no enhanced risk factors are present, the extent of enhanced customer due diligence measures to be applied in relation to that customer or potential customer is less than the extent to be applied in the case of a non-domestic PEP.
(4)In assessing the extent of the enhanced customer due diligence measures to be taken in relation to any particular person (which may differ from case to case), a relevant person—
(a)must take account of any relevant information made available to the relevant person under regulations 17(9) and 47; and
(b)may take into account any guidance which has been—
(i)issued by the FCA; or
(ii)issued by any other supervisory authority or appropriate body and approved by the Treasury.
(5)A relevant person who proposes to have, or to continue, a business relationship with a PEP, or a family member or a known close associate of a PEP, must, in addition to the measures required by regulation 33—
(a)have approval from senior management for establishing or continuing the business relationship with that person;
(b)take adequate measures to establish the source of wealth and source of funds which are involved in the proposed business relationship or transactions with that person; and
(c)where the business relationship is entered into, conduct enhanced ongoing monitoring of the business relationship with that person.
(6)A relevant person which is providing a customer with a contract of long-term insurance (an “insurance policy”) must take reasonable measures to determine whether one or more of the beneficiaries of the insurance policy or the beneficial owner of a beneficiary of such an insurance policy are—
(a)PEPs, or
(b)family members or known close associates of PEPs.
(7)The measures required under paragraph (6) must be taken before—
(a)any payment is made under the insurance policy, or
(b)the benefit of the insurance policy is assigned in whole or in part to another person.
(8)A relevant person must, in addition to the measures required by regulation 33, ensure that—
(a)its senior management is informed before it pays out any sums under an insurance policy the beneficiary of which is a PEP or a person who comes within paragraph (6)(b) in relation to a PEP, and
(b)its entire business relationship with the holder of the insurance policy (“the policy holder”) is scrutinised on an ongoing basis in accordance with enhanced procedures, whether or not the policy holder is a PEP or a family member or known close associate of a PEP.
(9)Where a person who was a PEP is no longer entrusted with a prominent public function, a relevant person must continue to apply the requirements in paragraphs (5) and (8) in relation to that person—
(a)for a period of at least 12 months after the date on which that person ceased to be entrusted with that public function; or
(b)for such longer period as the relevant person considers appropriate to address risks of money laundering or terrorist financing in relation to that person.
(10)Paragraph (9) does not apply in relation to a person who—
(a)was not a politically exposed person within the meaning of regulation 14(5) of the Money Laundering Regulations 2007 , when those Regulations were in force; and
(b)ceased to be entrusted with a prominent public function before the date on which these Regulations come into force.
(11)When a person who was a PEP is no longer entrusted with a prominent public function, the relevant person is no longer required to apply the requirements in paragraphs (5) and (8) in relation to a family member or known close associate of that PEP (whether or not the period referred to in paragraph (9) has expired).
(12)In this regulation—
(a)“politically exposed person” or “PEP” means an individual who is entrusted with prominent public functions, other than as a middle-ranking or more junior official;
(b)“family member” of a politically exposed person includes—
(i)a spouse or civil partner of the PEP;
(ii)children of the PEP and the spouses or civil partners of the PEP's children;
(iii)parents of the PEP;
(c)“known close associate” of a PEP means—
(i)an individual known to have joint beneficial ownership of a legal entity or a legal arrangement or any other close business relations with a PEP;
(ii)an individual who has sole beneficial ownership of a legal entity or a legal arrangement which is known to have been set up for the benefit of a PEP;
(d)“domestic PEP” means a politically exposed person entrusted with prominent public functions by the United Kingdom;
(e)“non-domestic PEP” means a politically exposed person who is not a domestic PEP;
(f)“enhanced risk factors”, in relation to a customer or potential customer who is a domestic PEP or a family member or a known close associate of that domestic PEP, mean risk factors other than the customer’s or potential customer’s position as a domestic PEP or as a family member or a known close associate of that domestic PEP.
(13)For the purposes of paragraph (5), a reference to a business relationship with an individual includes a reference to a business relationship with a person of which the individual is a beneficial owner.
(14)For the purposes of paragraphs (9), (11) and (12), individuals entrusted with prominent public functions include—
(a)heads of state, heads of government, ministers and deputy or assistant ministers;
(b)members of parliament or of similar legislative bodies;
(c)members of the governing bodies of political parties;
(d)members of supreme courts, of constitutional courts or of any judicial body the decisions of which are not subject to further appeal except in exceptional circumstances;
(e)members of courts of auditors or of the boards of central banks;
(f)ambassadors, charges d'affaires and high-ranking officers in the armed forces;
(g)members of the administrative, management or supervisory bodies of State-owned enterprises;
(h)directors, deputy directors and members of the board or equivalent function of an international organisation.
(15)For the purpose of deciding whether a person is a known close associate of a politically exposed person, a relevant person need only have regard to information which is in its possession, or to credible information which is publicly available.
Full captured verbatim text
(1) A relevant person must have in place appropriate risk-management systems and procedures to determine whether a customer or the beneficial owner of a customer is—

(a) a politically exposed person (a “PEP”); or

(b) a family member or a known close associate of a PEP,

and to manage the enhanced risks arising from the relevant person's business relationship or transactions with such a customer.

(2) In determining what risk-management systems and procedures are appropriate under paragraph (1), the relevant person must take account of—

(a) the risk assessment it carried out under regulation 18(1);

(b) the level of risk of money laundering and terrorist financing inherent in its business;

(c) the extent to which that risk would be increased by its business relationship or transactions with a PEP, or a family member or known close associate of a PEP, and

(d) any relevant information made available to the relevant person under regulations 17(9) and 47.

(3) If a relevant person has determined that a customer or a potential customer is a PEP, or a family member or known close associate of a PEP, the relevant person must assess—

(a) the level of risk associated with that customer, and

(b) the extent of the enhanced customer due diligence measures to be applied in relation to that customer.

(3A) For the purpose of the relevant person’s assessment under paragraph (3), where a customer or potential customer is a domestic PEP, or a family member or a known close associate of a domestic PEP—

(a) the starting point for the assessment is that the customer or potential customer presents a lower level of risk than a non-domestic PEP, and

(b) if no enhanced risk factors are present, the extent of enhanced customer due diligence measures to be applied in relation to that customer or potential customer is less than the extent to be applied in the case of a non-domestic PEP.

(4) In assessing the extent of the enhanced customer due diligence measures to be taken in relation to any particular person (which may differ from case to case), a relevant person—

(a) must take account of any relevant information made available to the relevant person under regulations 17(9) and 47; and

(b) may take into account any guidance which has been—

(i) issued by the FCA; or

(ii) issued by any other supervisory authority or appropriate body and approved by the Treasury.

(5) A relevant person who proposes to have, or to continue, a business relationship with a PEP, or a family member or a known close associate of a PEP, must, in addition to the measures required by regulation 33—

(a) have approval from senior management for establishing or continuing the business relationship with that person;

(b) take adequate measures to establish the source of wealth and source of funds which are involved in the proposed business relationship or transactions with that person; and

(c) where the business relationship is entered into, conduct enhanced ongoing monitoring of the business relationship with that person.

(6) A relevant person which is providing a customer with a contract of long-term insurance (an “insurance policy”) must take reasonable measures to determine whether one or more of the beneficiaries of the insurance policy or the beneficial owner of a beneficiary of such an insurance policy are—

(a) PEPs, or

(b) family members or known close associates of PEPs.

(7) The measures required under paragraph (6) must be taken before—

(a) any payment is made under the insurance policy, or

(b) the benefit of the insurance policy is assigned in whole or in part to another person.

(8) A relevant person must, in addition to the measures required by regulation 33, ensure that—

(a) its senior management is informed before it pays out any sums under an insurance policy the beneficiary of which is a PEP or a person who comes within paragraph (6)(b) in relation to a PEP, and

(b) its entire business relationship with the holder of the insurance policy (“the policy holder”) is scrutinised on an ongoing basis in accordance with enhanced procedures, whether or not the policy holder is a PEP or a family member or known close associate of a PEP.

(9) Where a person who was a PEP is no longer entrusted with a prominent public function, a relevant person must continue to apply the requirements in paragraphs (5) and (8) in relation to that person—

(a) for a period of at least 12 months after the date on which that person ceased to be entrusted with that public function; or

(b) for such longer period as the relevant person considers appropriate to address risks of money laundering or terrorist financing in relation to that person.

(10) Paragraph (9) does not apply in relation to a person who—

(a) was not a politically exposed person within the meaning of regulation 14(5) of the Money Laundering Regulations 2007 , when those Regulations were in force; and

(b) ceased to be entrusted with a prominent public function before the date on which these Regulations come into force.

(11) When a person who was a PEP is no longer entrusted with a prominent public function, the relevant person is no longer required to apply the requirements in paragraphs (5) and (8) in relation to a family member or known close associate of that PEP (whether or not the period referred to in paragraph (9) has expired).

(12) In this regulation—

(a) “politically exposed person” or “PEP” means an individual who is entrusted with prominent public functions, other than as a middle-ranking or more junior official;

(b) “family member” of a politically exposed person includes—

(i) a spouse or civil partner of the PEP;

(ii) children of the PEP and the spouses or civil partners of the PEP's children;

(iii) parents of the PEP;

(c) “known close associate” of a PEP means—

(i) an individual known to have joint beneficial ownership of a legal entity or a legal arrangement or any other close business relations with a PEP;

(ii) an individual who has sole beneficial ownership of a legal entity or a legal arrangement which is known to have been set up for the benefit of a PEP;

(d) “domestic PEP” means a politically exposed person entrusted with prominent public functions by the United Kingdom;

(e) “non-domestic PEP” means a politically exposed person who is not a domestic PEP;

(f) “enhanced risk factors”, in relation to a customer or potential customer who is a domestic PEP or a family member or a known close associate of that domestic PEP, mean risk factors other than the customer’s or potential customer’s position as a domestic PEP or as a family member or a known close associate of that domestic PEP.

(13) For the purposes of paragraph (5), a reference to a business relationship with an individual includes a reference to a business relationship with a person of which the individual is a beneficial owner.

(14) For the purposes of paragraphs (9), (11) and (12), individuals entrusted with prominent public functions include—

(a) heads of state, heads of government, ministers and deputy or assistant ministers;

(b) members of parliament or of similar legislative bodies;

(c) members of the governing bodies of political parties;

(d) members of supreme courts, of constitutional courts or of any judicial body the decisions of which are not subject to further appeal except in exceptional circumstances;

(e) members of courts of auditors or of the boards of central banks;

(f) ambassadors, charges d'affaires and high-ranking officers in the armed forces;

(g) members of the administrative, management or supervisory bodies of State-owned enterprises;

(h) directors, deputy directors and members of the board or equivalent function of an international organisation.

(15) For the purpose of deciding whether a person is a known close associate of a politically exposed person, a relevant person need only have regard to information which is in its possession, or to credible information which is publicly available.

What this provision means

Model summary, checked against the text on the left.

Relevance to Signicat: 3/3 · detailed summary (L4) Status: ok · Stored artifact; current recipe verification unavailable

Relevant persons must maintain risk systems to identify PEPs, obtain senior management approval, and verify sources of wealth and funds.

(1) A relevant person must have in place appropriate risk-management systems and procedures to determine whether a customer or the beneficial owner of a customer is—
(5) A relevant person who proposes to have, or to continue, a business relationship with a PEP, or a family member or a known close associate of a PEP, must, in addition to the measures required by regulation 33—
(9) Where a person who was a PEP is no longer entrusted with a prominent public function, a relevant person must continue to apply the requirements in paragraphs (5) and (8) in relation to that person—
Under (1), a relevant person must have risk-management systems to determine whether a customer or beneficial owner is a PEP, family member, or known close associate. Under (5), relevant persons must obtain senior management approval before establishing or continuing such relationships, take adequate measures to establish source of wealth and funds, and conduct enhanced ongoing monitoring. Under (6)-(8), life insurance providers must determine PEP status of beneficiaries prior to payment or assignment and inform senior management. Under (9), PEP requirements continue for at least 12 months post-office.
screening.pep_sanctions_adverse_mediamonitoring.ongoing_kycmonitoring.transactions_aml

Refers to

cross-reference internal_cite · reg. 17

cross-reference internal_cite · reg. 18

cross-reference internal_cite · reg. 33

cross-reference internal_cite · reg. 47

Referred to by

cross-reference internal_cite · reg. 19

cross-reference internal_cite · reg. 3

cross-reference internal_cite · reg. 33

cross-reference internal_cite · reg. 38

cross-reference internal_cite · reg. 40

cross-reference internal_cite · reg. 48

cross-reference internal_cite · Sch. 6 para. 7

cross-reference internal_cite · Sch. 7 para. 3

Part summaries

0 of 0 parts have a verified summary.

L1 unavailable for current verification: the overall summary needs every part verified. Provisions and the verified summaries remain readable.

Verification findings (348)

synthesis coverage: missing/unverified L2 part-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-3

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-4

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-5

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-6

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-7

synthesis coverage: missing/unverified L2 part-2-chapter-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-8

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-9

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-10

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-11

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-12

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-13

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-14

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-14A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-15

synthesis coverage: missing/unverified L2 part-2-chapter-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-16

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-16A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-17

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-18

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-18A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-19

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-19A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-20

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-21

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-22

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-23

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-24

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-25

synthesis coverage: missing/unverified L2 part-2-chapter-3

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-26

synthesis coverage: missing/unverified L2 part-3-chapter-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-27

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-28

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-29

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-30

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-30ZA

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-30A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-31

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-32

synthesis coverage: missing/unverified L2 part-3-chapter-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-33

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-34

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-35

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-36

synthesis coverage: missing/unverified L2 part-3-chapter-3

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-37

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-38

synthesis coverage: missing/unverified L2 part-4

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-39

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-40

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-41

synthesis coverage: missing/unverified L2 part-5

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-42

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-43

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-44

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45ZA

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45ZB

synthesis coverage: missing/unverified L2 part-5A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45B

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45C

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45D

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45E

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45F

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45G

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45H

synthesis coverage: missing/unverified L2 part-6-chapter-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-46

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-46A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-47

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-48

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-49

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-50

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-51

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-52

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-52A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-52B

synthesis coverage: missing/unverified L2 part-6-chapter-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-53

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-54

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-55

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-56

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-56A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-56B

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-57

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-58

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-58A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-59

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-60

synthesis coverage: missing/unverified L2 part-6-chapter-3

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-60A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-60B

synthesis coverage: missing/unverified L2 part-7

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-61

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-62

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-63

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64

synthesis coverage: missing/unverified L2 part-7A-chapter-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64B

synthesis coverage: missing/unverified L2 part-7A-chapter-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64C

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64D

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64E

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64F

synthesis coverage: missing/unverified L2 part-7A-chapter-3

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64G

synthesis coverage: missing/unverified L2 part-7A-chapter-4

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64H

synthesis coverage: missing/unverified L2 part-8

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-65

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-66

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-67

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-68

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-69

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-70

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-71

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-72

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-73

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-74

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-74A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-74B

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-74C

synthesis coverage: missing/unverified L2 part-9-chapter-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-75

synthesis coverage: missing/unverified L2 part-9-chapter-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-76

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-77

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-78

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-79

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-80

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-81

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-82

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-83

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-84

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-85

synthesis coverage: missing/unverified L2 part-9-chapter-3

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-86

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-87

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-88

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-89

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-90

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-91

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-92

synthesis coverage: missing/unverified L2 part-10-chapter-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-93

synthesis coverage: missing/unverified L2 part-10-chapter-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-94

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-95

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-96

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-97

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-98

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-99

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-100

synthesis coverage: missing/unverified L2 part-11

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-101

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-102

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-103

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-104

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-104A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-105

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-106

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-107

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-108

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-109

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-110

synthesis coverage: missing/unverified L2 schedule-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-21

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-22

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-23

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-24

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-25

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-26

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-27

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-27A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-28

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-29

synthesis coverage: missing/unverified L2 schedule-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-30

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-31

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-32

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-33

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-34

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-35

synthesis coverage: missing/unverified L2 schedule-3AZA

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3AZA-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3AZA-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3AZA-paragraph-3

synthesis coverage: missing/unverified L2 schedule-3A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-1A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-6A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-8A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-9A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-9B

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-21

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-22

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-23

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-23A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-24

synthesis coverage: missing/unverified L2 schedule-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-12A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-15A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-19

synthesis coverage: missing/unverified L2 schedule-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-5-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-5-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-5-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-5-paragraph-4

synthesis coverage: missing/unverified L2 schedule-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-9A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-11A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-13

synthesis coverage: missing/unverified L2 schedule-6A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-16

synthesis coverage: missing/unverified L2 schedule-6B

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6B-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6B-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6B-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6B-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6B-paragraph-5

synthesis coverage: missing/unverified L2 schedule-7-part-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-11

synthesis coverage: missing/unverified L2 schedule-7-part-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-21

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-22

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-23

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-24

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-25

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-26

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-27

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-28

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-29

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-30

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-31

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-32

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-33

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-34

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-35

Instrument tier unavailable

Change history as published

Reg. 22 omitted (31.12.2020) by virtue of The Money Laundering and Transfer of Funds (Information) (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/253), regs. 1(2), 5(4) (with savings in S.I. 2019/680, reg. 11); 2020 c. 1, Sch. 5 para. 1(1)

Pt. 5A omitted (1.9.2022) by virtue of The Money Laundering and Terrorist Financing (Amendment) (No. 2) Regulations 2022 (S.I. 2022/860), regs. 1(5), 10 · repeated 8×

Sch. 7 para. 27 revoked (24.2.2025) by The Procurement Act 2023 (Consequential and Other Amendments) Regulations 2025 (S.I. 2025/163), reg. 1(2), Sch. Pt. 2

Pending effects amendments not yet applied to this text

reg. 3(1) words inserted by The Money Laundering and Transfer of Funds (Information) (Amendment) (EU Exit) Regulations 2019 reg. 3(b) · Effective date unknown · reg. 3

reg. 34A inserted by The Money Laundering and Terrorist Financing (Amendment) Regulations 2026 reg. 20 · Effective date unknown

Sch. 6 para. 7(ga) inserted by The Money Laundering and Terrorist Financing (Amendment) Regulations 2026 reg. 36(b) · Effective date unknown · Sch. 6 para. 7

Provenance

Every claim the system makes about this text is traceable to these identifiers.

Instrument
uk:uksi/2017/692
Part
CHAPTER 2 Enhanced customer due diligence
Version
c5a0271554697d8359bede8a…
Content hash
sha256 e405ba10807abd30a659773e…
Source
legislation.gov.uk/uksi/2017/692